Abstract
Advances in neuroimaging have modified our knowledge on cerebral vein thrombosis (CVT). This disease is now diagnosed more frequently, and increasing evidence as to what are the most common risk factors and on the natural history of the disease is becoming available. Most patients with CVT have a benign prognosis: only a minority of patients die during the acute phase or in the following months. Most patients surviving CVT recover completely, or have only mild functional or cognitive deficits. Unfractionated or low-molecular weight heparin is widely used as a first-line therapy of CVT, despite the absence of conclusive evidence about the safety and efficacy in this setting. Vitamin K antagonists are usually prescribed for secondary prevention, but the optimal duration of treatment remains unknown. Because most patients with CVT have partial or complete recanalization of the vessels within the first few months after the index event, and because recurrences of CVT after a first episode appear to be uncommon, routine use of long-term therapy or event life-long secondary prevention seem to be unnecessary.
Similar content being viewed by others
References
Stam J (2005) Thrombosis of the cerebral veins and sinuses. N Engl J Med 352:1791–1798
Ameri A, Bousser MG (1992) Cerebral venous thrombosis. Neurol Clin 10:87–111
Gates PC (1986) Cerebral venous thrombosis. A retrospective review. Aust NZ J Med 16:766–770
Barnett HJ, Hyland HH (1953) Non-infective intracranial venous thrombosis. Brain 76:36–49
Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35:664–670
Dentali F, Crowther M, Ageno W (2006) Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 107:2766–2773
Lichy C, Dong-Si T, Reuner K et al (2006) Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fi brinolytic systems. J Neurol 253:316–320
Le Cam-Duchez V, Bagan-Triquenot A, Barbay V, Mihout B, Borg JY (2008) The G79A polymorphism of protein Z gene is an independent risk factor for cerebral venous thrombosis. J Neurol 255:1521–1525
Libourel EJ, ten Kate MK, Brouwer JL, Veeger NJ, van der Meer J (2007) Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis. Thromb Res 121:301–307
Wysokinska EM, Wysokinski WE, Brown RD, Karnicki K, Gosk-Beirska I, Grill D, McBane RD II (2008) Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 70:627–633
Wasay M, Bakshi R, Bobustuc G, Kojan S, Sheikh Z, Dai A, Cheema Z (2008) Cerebral venous thrombosis: analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis 17:49–54
de Bruijn SF, Stam J, Kappelle LJ (1996) Thunderclap headache as first symptom of cerebral venous sinus thrombosis. Lancet 348:1623–1625
Bousser MG, Ferro JM (2007) Cerebral venous thrombosis; an update. Lancet Neurol 6:162–170
Ferro JM, Lopes MG, Rosas MJ et al (2005) Delay in hospital admission of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 19:152–156
Van den Bergh WM, van der Schaaf I, van Gijn J (2005) The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 65:192–196
Ferro JM, Correia M, Rosas MJ et al (2003) Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 15:78–83
Kosinski CM, Mull M, Schwarz M et al (2004) Do normal d-dimer levels reliably exclude cerebral sinus thrombosis? Stroke 35:2820–2825
Crassard I, Soria C, Ch Tzourio et al (2005) A negative d-dimer assay does not rule out cerebral venous thrombosis: a series of 73 patients. Stroke 36:1716–1719
Bousser MG (2000) Cerebral venous thrombosis: diagnosis and management. J Neurol 247:252–258
Majoie CB, van Straten M, Venema HW, den Heeten GJ (2004) Multisection CT venography of the dural sinuses and cerebral veins by using matched mask bone elimination. Am J Neuroradiol 25:787–791
Ducreux D, Oppenheim C, Vandamme X et al (2001) Diffusion weighted imaging patterns of brain damage associated with cerebral venous thrombosis. Am J Neuroradiol 22:261–268
Chu K, Kang DW, Yoon BW, Roh JK (2001) Diffusion-weighted magnetic resonance in cerebral venous thrombosis. Arch Neurol 58:1569–1576
Lafitte F, Boukobza M, Guichard JP et al (1997) MRI and MRA for diagnosis and follow up of cerebral venous thrombosis (CVT). Clin Radiol 52:672–679
Dormont D, Anxionnat R, Evrard S, Louaille C, Chiras J, Marsault C (1994) MRI in cerebral venous thrombosis. J Neuroradiol 21:81–99
Masuhr F, Mehraein S, Einhäupl K (2004) Cerebral venous and sinus thrombosis. J Neurol 251:11–23
Selim M, Fink J, Linfante I, Kumar S, Schlaug G, Caplan LR (2002) Diagnosis of cerebral venous thrombosis with echo-planar T2*SW-weighted magnetic resonance imaging. Arch Neurol 59:1021–1026
Cakmak S, Hermier M, Montavont A et al (2004) T2*SW-weighted MRI in cortical venous thrombosis. Neurology 63:1698
Idbaih A, Boukobza M, Crassard I, Porcher R, Bousser MG, Chabriat H (2006) MRI of clot in cerebral venous thrombosis high diagnostic value of susceptibility-weighted images. Stroke 37:991–995
Einhaupl KM, Villringer A, Meister W et al (1991) Heparin treatment in sinus venous thrombosis. Lancet 338:597–600
de Bruijn SF, Stam J (1999) Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 30:484–488
Stam J, De Bruijn SF, DeVeber G (2002) Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 4:CD002005
Einhäupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F, Stam J (2006) EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 13:553–559
Ciccone A, Canhão P, Falcão F, Ferro JM, Sterzi R (2004) Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev 1:CD003693
Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N, Unwin DH (2001) Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke 32:2310–2317
Stam J, Majoie CB, van Delden OM, van Lienden KP, Reekers JA (2008) Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: a prospective study. Stroke 39:1487–1490
Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P, American College of Chest Physicians (2008) Antithrombotic and thrombolytic therapy for ischaemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(Suppl 6):630S–669S
Sacco RL, Adams R, Albers G, American Heart Association/American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology et al (2006) Guidelines for prevention of stroke in patients with ischaemic stroke or transient ischaemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 113:e409–e449
Scottish Intercollegiate Guideline Network (2008) Management of patients with stroke or TIA: assessment, Investigation, immediate management and secondary prevention. SIGN, Edinburgh
Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, Investigators ISCVT (2008) Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke 39:1152–1158
Gosk-Bierska I, Wysokinski W, Brown RD Jr et al (2006) Cerebral venous sinus thrombosis: incidence of venous thrombosis recurrence and survival. Neurology 67:814–819
Ferro JM, Lopes MG, Rosas MJ, Group CerebralVenousThrombosisPortugueseCollaborativeStudy et al (2002) Long-term prognosis of cerebral vein and dural sinus thrombosis. Results of the VENOPORT study. Cerebrovasc Dis 13:272–278
Dentali F, Gianni M, Crowther MA, Ageno W (2006) Natural history of cerebral vein thrombosis: a systematic review. Blood 108:1129–1134
de Bruijn SF, de Haan RJ, Stam J (2001) Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry 70:105–108
Stolz E, Rahimi A, Gerriets T et al (2005) Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome. Clin Neurol Neurosurg 107:99–107
Girot M, Ferro JM, Canhao P, Investigators ISCVT et al (2007) Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 38:337–342
Masuhr F, Busch M, Amberger N et al (2006) Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol 13:852–856
Appenzeller S, Zeller CB, Annichino-Bizzachi JM et al (2005) Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg 107:371–378
Mehraein S, Ortwein H, Busch M et al (2003) Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry 74:814–816
Stolz E, Trittmacher S, Rahimi A et al (2004) Influence of recanalization on outcome in dural sinus thrombosis: a prospective study. Stroke 35:544–547
Strupp M, Covi M, Seelos K et al (2002) Cerebral venous thrombosis: correlation between recanalization and clinical outcome: a long-term follow-up of 40 patients. J Neurol 249:1123–1124
Conflict of interest statement
The authors certify that they have no affiliation with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the manuscript (e.g. employment, consultancies, stock ownership and honoraria).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dentali, F., Ageno, W. Cerebral vein thrombosis. Intern Emerg Med 5, 27–32 (2010). https://doi.org/10.1007/s11739-009-0329-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-009-0329-1